Visual Field Restoration in Patients With Post-stroke Homonymous Hemianopsia
Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Aug 29, 2016
Trial Information
Current as of May 30, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of an homonymous visual field amputation after vascular retrochiasmatic lesion of the occipital region (visual cortex alone or with optical radiations or with other associated occipital areas)
- • inclusion 3 months to 36 months after stroke
- • Patients aged 18 years and older
- Exclusion criteria:
- • Brain injury history
- • Severe neuropsychological, psychiatric or behavioral disorder
- • Severe eye disorder or visual impairment (visual acuity less than 3/10)
- • Progressive eye disorder (cataracts or glaucoma)
- • insufficient French language proficiency to understand the questionnaires and rehabilitation tasks
- • patient under legal protection
- • patient's opposition to participate in the study
- • no medical insurance coverage
- • pregnant pr breastfeeding patient
About Fondation Ophtalmologique Adolphe De Rothschild
The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Sylvie CHOKRON
Study Director
Fondation OPH A de Rothschild
Olivier GOUT, MD
Principal Investigator
Fondation OPH A de Rothschild
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials